| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
1 company
Encrantz Staffan is a Director, 10% Owner at Sight Sciences, Inc.. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $7.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | SGHT Sight Sciences, Inc. | Director, 10% Owner | Buy | 3,462 | $2.00 | $6,913.61 | +12.8% | +118.0% | +93.2% | |
| May 17, 2022 | SGHT Sight Sciences, Inc. | Director, 10% Owner | Buy | 551,802 | $8.33 | $4,598,106.94 | +181.8% | +0.8% | +11.2% | |
| Dec 1, 2021 | SGHT Sight Sciences, Inc. | Director | Buy | 525,000 | $20.89 | $10,968,303.24 | +1.8% | -13.5% | -41.2% | |
| Oct 18, 2021 | SGHT Sight Sciences, Inc. | Director | Buy | 527,048 | $24.00 | $12,649,152.00 | +17.7% | -35.1% | -68.7% |